Global Recombinant Proteins Market 2023-2027

Description

List of Tables

Technavio has been monitoring the recombinant proteins market and is forecast to grow by USD 650.96 mn during 2022-2027, accelerating at a CAGR of 9.46% during the forecast period. Our report on the recombinant proteins market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in chronic diseases, rising inclination toward biologics and biosimilars, and technological advancements in production of recombinant proteins.

Technavio's recombinant proteins market is segmented as below:

By Application

Biotechnology research
Drug discovery and development
Biopharmaceutical production
Others

By End-user

Pharma and biotechnology companies
Academic and research institutes
Others

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in collaborations and strategic alliances by vendors as one of the prime reasons driving the recombinant proteins market growth during the next few years. Also, increased expenditure on R and D and growing opportunities from emerging economies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the recombinant proteins market covers the following areas:

Recombinant proteins market sizing
Recombinant proteins market forecast
Recombinant proteins market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading recombinant proteins market vendors that include Abcam plc, Airway Therapeutics Inc., Amgen Inc., Aviva Systems Biology Corp., Bio Techne Corp., Bio Rad Laboratories Inc., BPS Bioscience Inc., Elabscience Biotechnology Inc., Enzo Biochem Inc., GenScript Biotech Corp., Grifols SA, Merck KGaA, Novartis AG, Novo Nordisk AS, OriGene Technologies Inc., Prospec Tany Technogene Ltd., Proteintech Group Inc., Sanofi SA, Sino Biological Inc., and Thermo Fisher Scientific Inc. Also, the recombinant proteins market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR74151

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global recombinant proteins market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global recombinant proteins market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Biotechnology research - Market size and forecast 2022-2027
Exhibit 34: Chart on Biotechnology research - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Biotechnology research - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Biotechnology research - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Biotechnology research - Year-over-year growth 2022-2027 (%)
6.4 Drug discovery and development - Market size and forecast 2022-2027
Exhibit 38: Chart on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Drug discovery and development - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Drug discovery and development - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Drug discovery and development - Year-over-year growth 2022-2027 (%)
6.5 Biopharmaceutical production - Market size and forecast 2022-2027
Exhibit 42: Chart on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Biopharmaceutical production - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Biopharmaceutical production - Year-over-year growth 2022-2027 (%)
6.6 Others - Market size and forecast 2022-2027
Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
6.7 Market opportunity by Application
Exhibit 50: Market opportunity by Application ($ million)
Exhibit 51: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 54: Chart on Comparison by End-user
Exhibit 55: Data Table on Comparison by End-user
7.3 Pharma and biotechnology companies - Market size and forecast 2022-2027
Exhibit 56: Chart on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Pharma and biotechnology companies - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Pharma and biotechnology companies - Year-over-year growth 2022-2027 (%)
7.4 Academic and research institutes - Market size and forecast 2022-2027
Exhibit 60: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 64: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 67: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 68: Market opportunity by End-user ($ million)
Exhibit 69: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 71: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 72: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 73: Chart on Geographic comparison
Exhibit 74: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 95: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Italy - Market size and forecast 2022-2027
Exhibit 103: Chart on Italy - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on Italy - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on Italy - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on Italy - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 107: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 108: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 109: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 110: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 111: Market opportunity By Geographical Landscape ($ million)
Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 113: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 115: Overview on factors of disruption
11.4 Industry risks
Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 117: Vendors covered
12.2 Market positioning of vendors
Exhibit 118: Matrix on vendor position and classification
12.3 Abcam plc
Exhibit 119: Abcam plc - Overview
Exhibit 120: Abcam plc - Product / Service
Exhibit 121: Abcam plc - Key news
Exhibit 122: Abcam plc - Key offerings
12.4 Amgen Inc.
Exhibit 123: Amgen Inc. - Overview
Exhibit 124: Amgen Inc. - Product / Service
Exhibit 125: Amgen Inc. - Key offerings
12.5 Aviva Systems Biology Corp.
Exhibit 126: Aviva Systems Biology Corp. - Overview
Exhibit 127: Aviva Systems Biology Corp. - Product / Service
Exhibit 128: Aviva Systems Biology Corp. - Key offerings
12.6 Bio Rad Laboratories Inc.
Exhibit 129: Bio Rad Laboratories Inc. - Overview
Exhibit 130: Bio Rad Laboratories Inc. - Business segments
Exhibit 131: Bio Rad Laboratories Inc. - Key news
Exhibit 132: Bio Rad Laboratories Inc. - Key offerings
Exhibit 133: Bio Rad Laboratories Inc. - Segment focus
12.7 BPS Bioscience Inc.
Exhibit 134: BPS Bioscience Inc. - Overview
Exhibit 135: BPS Bioscience Inc. - Product / Service
Exhibit 136: BPS Bioscience Inc. - Key offerings
12.8 Enzo Biochem Inc.
Exhibit 137: Enzo Biochem Inc. - Overview
Exhibit 138: Enzo Biochem Inc. - Product / Service
Exhibit 139: Enzo Biochem Inc. - Key offerings
12.9 GenScript Biotech Corp.
Exhibit 140: GenScript Biotech Corp. - Overview
Exhibit 141: GenScript Biotech Corp. - Business segments
Exhibit 142: GenScript Biotech Corp. - Key news
Exhibit 143: GenScript Biotech Corp. - Key offerings
Exhibit 144: GenScript Biotech Corp. - Segment focus
12.10 Merck KGaA
Exhibit 145: Merck KGaA - Overview
Exhibit 146: Merck KGaA - Business segments
Exhibit 147: Merck KGaA - Key news
Exhibit 148: Merck KGaA - Key offerings
Exhibit 149: Merck KGaA - Segment focus
12.11 Novartis AG
Exhibit 150: Novartis AG - Overview
Exhibit 151: Novartis AG - Business segments
Exhibit 152: Novartis AG - Key offerings
Exhibit 153: Novartis AG - Segment focus
12.12 Novo Nordisk AS
Exhibit 154: Novo Nordisk AS - Overview
Exhibit 155: Novo Nordisk AS - Business segments
Exhibit 156: Novo Nordisk AS - Key offerings
Exhibit 157: Novo Nordisk AS - Segment focus
12.13 Prospec Tany Technogene Ltd.
Exhibit 158: Prospec Tany Technogene Ltd. - Overview
Exhibit 159: Prospec Tany Technogene Ltd. - Product / Service
Exhibit 160: Prospec Tany Technogene Ltd. - Key offerings
12.14 Proteintech Group Inc.
Exhibit 161: Proteintech Group Inc. - Overview
Exhibit 162: Proteintech Group Inc. - Product / Service
Exhibit 163: Proteintech Group Inc. - Key offerings
12.15 Sanofi SA
Exhibit 164: Sanofi SA - Overview
Exhibit 165: Sanofi SA - Business segments
Exhibit 166: Sanofi SA - Key news
Exhibit 167: Sanofi SA - Key offerings
Exhibit 168: Sanofi SA - Segment focus
12.16 Sino Biological Inc.
Exhibit 169: Sino Biological Inc. - Overview
Exhibit 170: Sino Biological Inc. - Product / Service
Exhibit 171: Sino Biological Inc. - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 172: Thermo Fisher Scientific Inc. - Overview
Exhibit 173: Thermo Fisher Scientific Inc. - Business segments
Exhibit 174: Thermo Fisher Scientific Inc. - Key news
Exhibit 175: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 176: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations